• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素-蛋白酶体途径在癌症发展和治疗中的作用。

The role of the ubiquitin-proteasome pathway in cancer development and treatment.

机构信息

Department of Cardiothoracic Surgery, Xinhua Hospital School of Medicine, Shanghai Jiaotong University, 1665 Kongjiang Road, Shanghai 200092, China.

出版信息

Front Biosci (Landmark Ed). 2014 Jun 1;19(6):886-95. doi: 10.2741/4254.

DOI:10.2741/4254
PMID:24896323
Abstract

Ubiquitination is a post-translational modification that plays a role in several cellular processes including cell cycle progression, cell proliferation, DNA replication and apoptosis. Ubiquitin-mediated signaling is frequently altered in cancer cells. Several tumor suppressors and oncogenes interact with enzymes of the ubiquitin-proteasome pathway that function in ubiquitin conjugation and deconjugation. Increasing evidence indicates that the ubiquitin-proteasome system (UPS) plays an important role in cancer development. Several small molecule inhibitors of the UPS have been applied to the treatment of cancer. The current review focuses on the role of the UPS in cancer development and the development of UPS inhibitors for cancer treatment.

摘要

泛素化是一种翻译后修饰,在几个细胞过程中发挥作用,包括细胞周期进展、细胞增殖、DNA 复制和细胞凋亡。泛素介导的信号在癌细胞中经常发生改变。几种肿瘤抑制因子和癌基因与参与泛素缀合和解缀合的泛素蛋白酶体途径的酶相互作用。越来越多的证据表明,泛素蛋白酶体系统(UPS)在癌症发展中起着重要作用。几种 UPS 的小分子抑制剂已应用于癌症的治疗。本综述重点介绍 UPS 在癌症发展中的作用以及用于癌症治疗的 UPS 抑制剂的开发。

相似文献

1
The role of the ubiquitin-proteasome pathway in cancer development and treatment.泛素-蛋白酶体途径在癌症发展和治疗中的作用。
Front Biosci (Landmark Ed). 2014 Jun 1;19(6):886-95. doi: 10.2741/4254.
2
Ubiquitination and deubiquitination: Implications on cancer therapy.泛素化和去泛素化:对癌症治疗的影响。
Biochim Biophys Acta Gene Regul Mech. 2023 Dec;1866(4):194979. doi: 10.1016/j.bbagrm.2023.194979. Epub 2023 Aug 24.
3
Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.泛素-蛋白酶体系统(UPS)作为抗癌治疗的靶点。
Arch Pharm Res. 2020 Nov;43(11):1144-1161. doi: 10.1007/s12272-020-01281-8. Epub 2020 Nov 9.
4
Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.泛素-蛋白酶体系统及其抑制剂在癌症治疗中的作用。
Open Biol. 2021 Apr;11(4):200390. doi: 10.1098/rsob.200390. Epub 2021 Apr 28.
5
Deubiquitinating enzyme inhibitors and their potential in cancer therapy.去泛素化酶抑制剂及其在癌症治疗中的潜力。
Curr Cancer Drug Targets. 2014;14(6):506-16. doi: 10.2174/1568009614666140725090620.
6
Ubiquitin networks in cancer.泛素化网络与癌症。
Curr Opin Genet Dev. 2011 Feb;21(1):21-8. doi: 10.1016/j.gde.2010.10.004. Epub 2010 Nov 9.
7
Targeting the ubiquitin proteasome system: beyond proteasome inhibition.靶向泛素蛋白酶体系统:超越蛋白酶体抑制。
Curr Pharm Des. 2013;19(22):4053-93. doi: 10.2174/1381612811319220014.
8
The role of the ubiquitin proteasome system in lymphoma.泛素蛋白酶体系统在淋巴瘤中的作用。
Crit Rev Oncol Hematol. 2013 Sep;87(3):306-22. doi: 10.1016/j.critrevonc.2013.02.005. Epub 2013 Mar 27.
9
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.靶向泛素-蛋白酶体通路克服抗癌药物耐药性。
Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11.
10
The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.泛素-蛋白酶体系统作为癌症治疗和预防的有前景的分子靶标。
Curr Protein Pept Sci. 2010 Sep;11(6):459-70. doi: 10.2174/138920310791824057.

引用本文的文献

1
Review to Elucidate the Correlation between Cuproptosis-Related Genes and Immune Infiltration for Enhancing the Detection and Treatment of Cervical Cancer.综述阐明铜死亡相关基因与免疫浸润的相关性,以增强宫颈癌的检测和治疗。
Int J Mol Sci. 2024 Oct 1;25(19):10604. doi: 10.3390/ijms251910604.
2
Prognostic value of NOB1 expression levels in various cancers: a systematic review and meta-analysis.NOB1 表达水平在各种癌症中的预后价值:系统评价和荟萃分析。
Biomark Med. 2024;18(13-14):619-628. doi: 10.1080/17520363.2024.2352408. Epub 2024 Jun 17.
3
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors.
蛋白酶体抑制剂与 NF-κB 通路在白血病和淋巴瘤中的相互作用:蛋白酶体抑制剂面临挑战的综合述评。
Cell Commun Signal. 2024 Feb 8;22(1):105. doi: 10.1186/s12964-023-01433-5.
4
UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.UBE2C 通过促进肿瘤迁移和侵袭作为子宫体子宫内膜癌的预后标志物。
Sci Rep. 2023 Oct 6;13(1):16899. doi: 10.1038/s41598-023-44189-1.
5
Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.USP2 抑制通过下调 Survivin 增强 TRAIL 介导的癌细胞死亡。
Int J Mol Sci. 2023 Aug 15;24(16):12816. doi: 10.3390/ijms241612816.
6
Interplay between proteasome function and inflammatory responses in e-cig vapor condensate-challenged lung epithelial cells.电子香烟蒸汽冷凝物刺激的肺上皮细胞中蛋白酶体功能与炎症反应的相互作用。
Arch Toxicol. 2023 Aug;97(8):2193-2208. doi: 10.1007/s00204-023-03504-5. Epub 2023 Jun 22.
7
Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line.微小帕毛单胞菌感染增强结直肠癌细胞系的增殖、伤口愈合和炎症反应。
Biosci Rep. 2023 Jun 28;43(6). doi: 10.1042/BSR20230609.
8
UPS: Opportunities and challenges for gastric cancer treatment.UPS:胃癌治疗的机遇与挑战。
Front Oncol. 2023 Apr 3;13:1140452. doi: 10.3389/fonc.2023.1140452. eCollection 2023.
9
Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling.敲低 RNF6 通过抑制 MAPK/ERK 信号通路抑制 HeLa 宫颈癌细胞生长。
FEBS Open Bio. 2021 Jul;11(7):2041-2049. doi: 10.1002/2211-5463.13216. Epub 2021 Jun 18.
10
Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity.脂联素与甲状腺癌:深入了解脂联素与肥胖之间的关联
Aging Dis. 2021 Apr 1;12(2):597-613. doi: 10.14336/AD.2020.0919. eCollection 2021 Apr.